Read & Download your Issue of Wednesday – January 20 FNN News

Trial of COVID-19 blood plasma finds no benefit in severely ill patients

• An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit.
• The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product – an antibody-rich plasma taken from people who have recovered from the pandemic disease – did not improve outcomes.

Source: Reuters

Association Between Number of In-Person Health Care Visits and SARS-CoV-2 Infection in Obstetrical Patients

• A major concern that has emerged from the coronavirus disease 2019 pandemic is patient avoidance of necessary medical care.
• Data regarding how in-person visits to medical facilities influence the risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited.
• Obstetrical patients are a unique group who have required frequent in-person health care visits during the pandemic.
• The aim of this analysis was to examine whether the number of in-person health care visits was associated with the risk of SARS-CoV-2 infection.

Source: JAMA Network

Fighting against COVID-19: Innovative strategies for clinical pharmacists

• Clinical pharmacists’ routine task is carrying out pharmaceutical care to ensure patients’ safe and reasonable medication use.
• However, under public health emergencies, such as the outbreak of COVID-19, the work strategies of clinical pharmacists need to be modified according to the rapid spread of the disease
• This study aims to retrieve and investigate the prevention and control measures of clinical pharmacists during the outbreak of novel coronavirus, summarize the roles and responsibilities of clinical pharmacists, and to propose innovative strategies for developing pharmacy services under the epidemic.

Source: ScienceDirect

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020

• Anaphylaxis is a severe, life-threatening allergic reaction that occurs rarely after vaccination.
• Locations administering COVID-19 vaccines should adhere to CDC guidance for use of COVID-19 vaccines, including screening recipients for contraindications and precautions, having the necessary supplies available to manage anaphylaxis, implementing the recommended postvaccination observation periods, and immediately treating suspected cases of anaphylaxis with intramuscular injection of epinephrine.

Source: CDC

4 Ways Clinical AI Will Transform Healthcare in 2021

• Having seen what AI can do, here are four predictions for how AI will impact healthcare in 2021
• A recent survey found 56 percent of healthcare executives accelerated their AI deployment plans in response to the pandemic.
• AI has helped hospitals manage capacity, triage CO-19 patients, and target outreach to vulnerable patients and populations to prevent avoidable hospitalizations.
• AI has also eased clinicians’ administrative burden.

Source: Healthcare Innovation

The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients

• Carbapenem-resistant Acinetobacter baumannii (CRAB) can cause life-threatening infections and nosocomial outbreaks.
• It can be transmitted via multiple fomites.
• The role of the computerized tomography (CT) scanner in cross-transmission has not been described.
• Performing a CT-scan within 6 hours of a CT-scan performed in a CRAB-positive patient was an independent predictor of CRAB acquisition, approximately tripling the risk.
• This probably reflects poor infection control practice in the CT-suite.

Source: CMI

• Read more from FADIC Blog, with many articles with evidence based articles.
• Learn More Through FADIC® – Online Programs & Mini-Courses.
• Listen Now to FADIC Podcast focusing on varieties of pharmacist perspectives in specialties.
• Read More Now about FADIC Pharmacy Events to get more Experience.

Course Copyrights:

All Courses is meant for SINGLE user use only.
If more than one person acceced this course, they will be BLOCKED Forever.

Why FADIC 2021 Clinical Research E-News ?

• It helps to keep up with the literature!
• Provide you with the Updated with the latest in your clinical practice. Wherever you are, and Whenever you need!
• Help you to share in the advance in clinical career. In addition to adding an impressive image to the pharmacists all-around!

Subscribe to FADIC 2021 Clinical Research FNN E-News, for a publication of News

Read & Download FNN Issue 8 of April 2020 FNN News